Sector: Consumer Non-Cyclicals | Industry: Tobacco |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 677 Washington Blvd, Ste. 1100 STAMFORD CT 06901 |
Tel: | 1-917-6632233 |
Website: | https://www.pmi.com |
IR: | See website |
Key People | ||
Andre Calantzopoulos Executive Chairman of the Board | Marco Mariotti President, CIS, Central Asia, Israel | Jacek Olczak Chief Executive Officer, Director |
Emmanuel Babeau Chief Financial Officer | Massimo Andolina President - Europe Region | Werner Barth President Combustibles Category and Global Combustibles Marketing |
Lars Dahlgren President, Smoke Free Oral Products and Chief Executive Officer, Swedish Match | Frederic De Wilde President, South and Southeast Asia (SSEA), Commonwealth of Independent States (CIS), Middle East and Africa (MEA) Region | Jorge Insuasty President, Vectura Fertin Pharma | Stacey Kennedy President, Americas Region and CEO of PMI's U.S. Business |
Business Overview |
Philip Morris International Inc. is an international tobacco company. The Company's product portfolio primarily consists of cigarettes and smoke-free products, which include heat-not-burn, vapor, and oral nicotine products. The Company's segments include Europe Region; South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region (SSEA, CIS & MEA); East Asia, Australia, and PMI Duty Free Region (EA, AU & PMI DF); Americas Region; Swedish Match, and Wellness and Healthcare (W&H), which includes the operating of Vectura Fertin Pharma business. The Company's brands include Marlboro, HEETS, IQOS, IQOS ILUMA, TEREA, and ZYN. The Company's IQOS smoke-free product brand portfolio includes heated tobacco and nicotine-containing vapor products. Its smoke-free platform (Platform 1) uses a precisely controlled heating device into which a specially designed and proprietary tobacco unit is inserted and heated to generate an aerosol. |
Financial Overview |
For the three months ended 31 March 2024, Philip Morris International Inc. revenues increased 9% to $8.79B. Net income applicable to common stockholders increased 8% to $2.14B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Interest expense, net increase of 30% to $299M (expense). Dividend per share increased from $1.27 to $1.30. |
Employees: | 82,700 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $200,351M as of Mar 31, 2024 |
Annual revenue (TTM): | $35,948M as of Mar 31, 2024 |
EBITDA (TTM): | $15,163M as of Mar 31, 2024 |
Net annual income (TTM): | $7,944M as of Mar 31, 2024 |
Free cash flow (TTM): | N/A |
Net Debt Last Fiscal Year: | $46,419M as of Mar 31, 2024 |
Shares outstanding: | 1,554,551,026 as of Mar 31, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |